A detailed history of Bank Of America Corp transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 26,907 shares of FHTX stock, worth $260,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,907
Previous 12,728 111.4%
Holding current value
$260,190
Previous $85,000 81.18%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.05 - $8.0 $71,603 - $113,432
14,179 Added 111.4%
26,907 $154,000
Q1 2024

May 15, 2024

SELL
$2.82 - $7.94 $46,092 - $129,779
-16,345 Reduced 56.22%
12,728 $85,000
Q4 2023

Feb 14, 2024

BUY
$2.94 - $6.76 $63,357 - $145,678
21,550 Added 286.45%
29,073 $187,000
Q2 2023

Aug 14, 2023

SELL
$5.37 - $8.84 $4,763 - $7,841
-887 Reduced 10.55%
7,523 $52,000
Q1 2023

May 12, 2023

SELL
$4.66 - $8.99 $26,930 - $51,953
-5,779 Reduced 40.73%
8,410 $52,000
Q4 2022

Feb 10, 2023

BUY
$5.44 - $9.46 $27,831 - $48,397
5,116 Added 56.39%
14,189 $90,000
Q3 2022

Nov 14, 2022

SELL
$7.52 - $18.01 $16,265 - $38,955
-2,163 Reduced 19.25%
9,073 $78,000
Q2 2022

Aug 12, 2022

SELL
$8.48 - $16.84 $32,156 - $63,857
-3,792 Reduced 25.23%
11,236 $152,000
Q1 2022

May 16, 2022

SELL
$8.87 - $22.1 $44,216 - $110,168
-4,985 Reduced 24.91%
15,028 $229,000
Q4 2021

Feb 08, 2022

BUY
$10.79 - $22.87 $86,676 - $183,714
8,033 Added 67.05%
20,013 $458,000
Q3 2021

Nov 15, 2021

SELL
$8.33 - $15.02 $2,415 - $4,355
-290 Reduced 2.36%
11,980 $167,000
Q2 2021

Sep 13, 2021

BUY
$9.32 - $13.26 $114,356 - $162,700
12,270 New
12,270 $131,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $403M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.